NEW YORK--The Guttman Institute, a pioneering breast cancer screening
center in Manhattan that provided low-cost screenings to women
for almost 30 years, has become a cancer diagnostic center serving
both men and women.
Memorial Sloan-Kettering Cancer Center acquired the Guttman Institute
in January of this year, renovated and expanded the facility,
and reopened it last July as the Memorial Sloan-Kettering Guttman
Diagnostic Center. The formerly pink-walled center once decorated
solely with women in mind, emerged from renovations with a wood-paneled
executive boardroom look and coed staff.
The new Guttman offers cervical, prostate, and colorectal screenings
as well as enhanced breast cancer detection, including ultrasound,
ultrasound-guided biopsy, and fine-needle aspirations.
The Guttman Center will continue to carry on the renowned work
of Dr. Philip Strax, the Institute's founder and original medical
director, Michael A. Cohen, MD, the new medical director, said
at the official reopening.
Dr. Strax was the principle investigator of the landmark 1963
Health Insurance Plan (HIP) of Greater New York trial, the first
randomized controlled study designed to prove the efficacy of
mammography screening, Dr. Cohen said. The HIP study showed a
30% reduction in women receiving yearly mam-mography and breast
physical examinations over those who received neither.
The women who were first enrolled in the study became the patients
of the Guttman Institute when Dr. Strax founded it in 1968, Dr.
Cohen noted. "His study literally christened mammography
as a legitimate screening modality."
The HIP trial still has relevance to issues facing today's oncologists
and radiologists, such as whether to screen women between the
ages of 40 and 49 for breast cancer, Dr. Cohen added.